AR017220A1 - Composicion farmaceutica que comprende micelas en un medio acuoso, proceso para su preparacion y empleo de la composicion farmaceutica para la fabricacionde un medicamento. - Google Patents

Composicion farmaceutica que comprende micelas en un medio acuoso, proceso para su preparacion y empleo de la composicion farmaceutica para la fabricacionde un medicamento.

Info

Publication number
AR017220A1
AR017220A1 ARP980106453A ARP980106453A AR017220A1 AR 017220 A1 AR017220 A1 AR 017220A1 AR P980106453 A ARP980106453 A AR P980106453A AR P980106453 A ARP980106453 A AR P980106453A AR 017220 A1 AR017220 A1 AR 017220A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
surfactant
preparation
stable
micelas
Prior art date
Application number
ARP980106453A
Other languages
English (en)
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR017220A1 publication Critical patent/AR017220A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP980106453A 1997-12-22 1998-12-17 Composicion farmaceutica que comprende micelas en un medio acuoso, proceso para su preparacion y empleo de la composicion farmaceutica para la fabricacionde un medicamento. AR017220A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (sv) 1997-12-22 1997-12-22 New formulation

Publications (1)

Publication Number Publication Date
AR017220A1 true AR017220A1 (es) 2001-08-22

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106453A AR017220A1 (es) 1997-12-22 1998-12-17 Composicion farmaceutica que comprende micelas en un medio acuoso, proceso para su preparacion y empleo de la composicion farmaceutica para la fabricacionde un medicamento.

Country Status (20)

Country Link
EP (1) EP1043973A1 (no)
JP (1) JP2001526210A (no)
KR (1) KR20010024789A (no)
CN (1) CN1283106A (no)
AR (1) AR017220A1 (no)
AU (1) AU1993599A (no)
BR (1) BR9813811A (no)
CA (1) CA2315782A1 (no)
EE (1) EE200000388A (no)
HU (1) HUP0102365A3 (no)
ID (1) ID26945A (no)
IL (1) IL136880A0 (no)
NO (1) NO20003220L (no)
NZ (1) NZ505073A (no)
PL (1) PL341361A1 (no)
SE (1) SE9704833D0 (no)
SK (1) SK9532000A3 (no)
TR (1) TR200001977T2 (no)
WO (1) WO1999032089A1 (no)
ZA (1) ZA9811461B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (sv) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005018607A1 (ja) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. 溶解性を改善した医薬品製剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
JP2011503113A (ja) * 2007-11-13 2011-01-27 メリテイジ ファーマ，インク． 胃腸炎の治療用組成物
WO2010029374A1 (en) * 2008-09-12 2010-03-18 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
CN101982168B (zh) * 2010-11-02 2012-05-23 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
NO20003220D0 (no) 2000-06-21
PL341361A1 (en) 2001-04-09
ZA9811461B (en) 1999-06-22
HUP0102365A3 (en) 2002-01-28
SK9532000A3 (en) 2000-11-07
IL136880A0 (en) 2001-06-14
AU1993599A (en) 1999-07-12
WO1999032089A1 (en) 1999-07-01
CA2315782A1 (en) 1999-07-01
ID26945A (id) 2001-02-22
SE9704833D0 (sv) 1997-12-22
BR9813811A (pt) 2000-10-03
KR20010024789A (ko) 2001-03-26
NO20003220L (no) 2000-08-22
CN1283106A (zh) 2001-02-07
HUP0102365A2 (hu) 2001-11-28
NZ505073A (en) 2002-09-27
JP2001526210A (ja) 2001-12-18
TR200001977T2 (tr) 2000-12-21
EE200000388A (et) 2002-02-15
EP1043973A1 (en) 2000-10-18

Similar Documents

Publication Publication Date Title
AR017220A1 (es) Composicion farmaceutica que comprende micelas en un medio acuoso, proceso para su preparacion y empleo de la composicion farmaceutica para la fabricacionde un medicamento.
Hassan et al. Chemical permeation enhancers for transbuccal drug delivery
DE69020422T3 (de) Zusammensetzung in Form eines Schaumes enthaltend 5-Aminosalicylic Säure zur intra-rektal Verabreichung.
ES2275948T3 (es) Un gel que contiene al menos un retinoide y un peroxido de benzoilo.
EP1898876B1 (en) Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical presentations
KR100686901B1 (ko) 점막 투여용 약제학적 조성물
Buajeeb et al. Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus
UA119324C2 (uk) Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
AR012358A1 (es) Formulaciones de liberacion prolongada de derivados de eritromicina y su uso para la manufactura de un medicamento
JP2004535361A (ja) 生体接着性の徐放性送達独立気泡発泡体フィルム
JP7497980B2 (ja) 体表面の障害の処置のためのデバイスおよび方法
US20240082332A1 (en) Method for obtaining an extract of a plant biomass
ES2234681T3 (es) Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa.
Holbrook et al. Aqueous hydrocortisone mouthwash solution: clinical evaluation
BR102015005689A2 (pt) Forma de dosagem liquida viscosa e seu uso, processo para a preparação de uma forma de dosagem, composição farmacêutica liquida
JP4824954B2 (ja) 口内炎治療のための口腔用組成物
CA2468906A1 (en) Use of selenite-containing compounds to be topically or buccally administered
WO2003105821A1 (en) A pharmaceutical composition comprising a corticosteroid and a nonsterodial anti-inflammatory agent
JPH07258070A (ja) 鼻洗浄剤
JP2012193159A (ja) 鼻用スプレー
KR20220055901A (ko) 점착성 고분자를 이용한 구강상처 보호 및 자가치료용 창상피복재
ITBO20090775A1 (it) Composizioni comprendenti antiinfiammatori non steroidei
ES2738652T3 (es) Composiciones de midazolam para administración bucal en el tratamiento de convulsiones para obtener comienzo de acción rápido
JPS62223114A (ja) 徐放性歯周病治療剤
CN115624520B (zh) 一种地奥司明乳膏剂和应用

Legal Events

Date Code Title Description
FA Abandonment or withdrawal